Comparison and validation of novel pyrogen tests based on the human fever reaction.

S. Schindler, T. Hartung

Research output: Contribution to journalArticlepeer-review


The absence of pyrogens (fever-inducing contamination) in injectable drugs is a crucial safety control because pyrogens can pose a life-threatening risk to the patient. The field of applications for pyrogen-testing is expanding and becoming more diverse due to innovative high-tech products such as medical devices, cellular therapies and species-specific agents (e.g. recombinant proteins). The overall aim of the consortium is to develop, evaluate and validate a method based on the human fever reaction to replace the rabbit pyrogen test and the Limulus assay. The network brings together the six most prominent test systems developed recently in Europe for trans-national comparison and subsequent validation of the most promising models. This pre-competitive development will initiate further applications and exploitations for new fields of pyrogen testing such as cellular therapies, medical devices and pyrogen pollution control in the work place. A method for introduction into the European Pharmacopoeia will be developed as a replacement for the rabbit pyrogen test for end-product control.

Original languageEnglish (US)
Pages (from-to)181-186
Number of pages6
JournalDevelopments in biologicals
StatePublished - 2002
Externally publishedYes

ASJC Scopus subject areas

  • Biomaterials
  • Immunology
  • Pharmacology


Dive into the research topics of 'Comparison and validation of novel pyrogen tests based on the human fever reaction.'. Together they form a unique fingerprint.

Cite this